Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $1,064.48, giving the company a market capitalization of 1T. It carries a P/E multiple of 37.50 and pays a dividend yield of 59.8%.
On 2026-05-22, Eli Lilly(LLY) stock traded between a low of $1,047.07 and a high of $1,069.11. Shares are currently priced at $1,064.48, which is +1.7% above the low and -0.4% below the high.
The Eli Lilly(LLY)'s current trading volume is 1.9M, compared to an average daily volume of 2.97M.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.
LLY News
...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Start a conversation with TipRanks’ trusted, data-backed investment intelligen...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Start a conversation with TipRanks’ trusted, data-backed investment intelligen...
Analyst ratings
85%
of 33 ratingsMore LLY News
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Start a conversation with TipRanks’ trusted, data-backed investment intelligen...
Eli Lilly And Company (LLY), Rigel Pharmaceuticals (RIGL) announced an update on their ongoing clinical study. Start a conversation with TipRanks’ trusted, dat...
Wondering whether Eli Lilly's share price still reflects fair value, or if expectations have started to run ahead of the fundamentals? This article breaks down...
The study evaluated retatrutide, a triple hormone receptor agonist targeting GIP, GLP-1, and glucagon pathways, in adults with obesity or overweight and at leas...
U.S. pharmaceutical giant Eli Lilly (LLY) says its next-generation weight-loss drug has cleared a late-stage clinical trial in patients who are obese. Start a...
Biotech and Pharma Eli Lilly’s New GLP-1 Drug Looks Like a Weight-Loss Powerhouse in New Trial In this article LLY NVO Eli Lilly shares have fallen around 5% so...
Truist keeps the firm’s Buy rating and a $1,281 price target on Eli Lilly (LLY). The company’s retatrutide Phase 3 clinical trial data in obesity announced this...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.